Study reveals acrylamide exposure alters Gstp and Gclc gene expression in rats, indicating impacts on antioxidant defense.
Introduction. Acrylamide is a toxicant encountered in both industrial and domestic settings. It forms during the thermal processing of food and is used in industrial processes, increasing the risk of human exposure. Acrylamide has nephrotoxic, neurotoxic, and genotoxic properties, but its impact on cellular mechanisms, including antioxidant and detoxification systems, remains insufficiently studied. Investigating the expression of the Gstp and Gclc genes, involved in antioxidant defense, is crucial for understanding the pathogenesis of acrylamide-induced changes.Th The aim of the work was to study the changes in the expression of the Gstp and Gclc genes under prolonged acrylamide exposure and to evaluate the effectiveness of preventive measures using oxymethyluracil-based compounds. Materials and methods. The experiment involved sixty male white rats received acrylamide (5 mg/kg body weight) daily for 90 days. Preventive correction was conducted one hour before acrylamide administration. Gene expression levels were assessed using real-time PCR. Results. Prolonged acrylamide exposure caused changes in the expression of the Gstp and Gclc genes in kidney tissue. The expression of Gstp significantly increased, especially in groups received preventive correction with ascorbic acid-containing compounds. The expression of Gclc initially decreased but increased after 3 months, particularly with the use of acetylcysteine and sodium succinate. Limitations. This study focused on evaluating the expression levels of two key Gstp and Gclc genes, associated with antioxidant defense under prolonged acrylamide exposure. However, to gain a more comprehensive understanding of the pathogenic mechanisms of acrylamide-induced nephrotoxicity, further analysis is required to include other genetic markers related to detoxification, inflammation, and oxidative stress. There is also needed the multifactorial approach, incorporating the assessment of biochemical and physiological indicators of toxic exposure. Conclusion. Acrylamide negatively affects kidney function, as evidenced by changes in the expression of Gstp and Gclc genes. The most effective prevention was observed with the use of oxymethyluracil combined with acetylcysteine.
No takes yet. Share an insight, caveat, or question.
Yakupova et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: